CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

about

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

Item

http://www.wikidata.org/entity/Q50245452

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@en

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@nl

type

Item

label

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@en

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@nl

prefLabel

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@en

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@nl

P1476

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

@en

P2093

Chaehwa Park

http://www.w3.org/2001/XMLSchema#string

Joo Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Kyung Ju Ryu

http://www.w3.org/2001/XMLSchema#string

Seok Jin Kim

http://www.w3.org/2001/XMLSchema#string

Won Seog Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Aggressive lymphomas

Signaling by the phosphoinositide 3-kinase family in immune cells

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.

A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL).

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

SDF-1 and CXCR4 in normal and malignant hematopoiesis.

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

P2888

s41408-018-0056-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-018-0056-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101165413

http://www.w3.org/2001/XMLSchema#string

P698

29472546

http://www.w3.org/2001/XMLSchema#string

P932

5823878

http://www.w3.org/2001/XMLSchema#string